 | |
| Clinical data | |
|---|---|
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C22H29N2O+ |
| Molar mass | 337.487 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Fenpiverinium is ananticholinergic andantispasmodic compound;[1] it is marketed as acombination drug withpitofenone hydrochloride and eithernimesulide ormetamizole in Eastern Europe and India to treat smooth muscle spasms and pain.[2]
The combination with metamizole was removed from the market in Lithuania for safety reasons in 2000[3] and a boxed warning against use by children and adolescents was added in Serbia in 2005.[4] In 2016 India banned marketing of the combination with nimesulide along with 344 other combination drugs;[5][6] the order was overturned in December and appealed by the Government in January 2017.[7]
 | Thisdrug article relating to thegastrointestinal system is astub. You can help Wikipedia byexpanding it. |
